Article ID Journal Published Year Pages File Type
11025456 Critical Reviews in Oncology/Hematology 2018 5 Pages PDF
Abstract
HRT use after RRSO in BRCA 1 and BRCA2 mutation carries does not affect BC risk. Comparison of the different HRT types suggests that estrogen alone should be related to lowest BC risk.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Hematology
Preview
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
Authors
, , , , , , , , , , ,